Status:
COMPLETED
Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation
Lead Sponsor:
Creighton University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
19+ years
Brief Summary
This study aims to evaluate the utility of the atrial electromechanical interval and pulse wave velocity in the prediction of recurrence of atrial fibrillation among patients who underwent successful ...
Detailed Description
This will be a prospective cohort study designed to evaluate the value of atrial electromechanical interval and pulse wave velocity in the prediction of recurrence of atrial fibrillation among patient...
Eligibility Criteria
Inclusion
- Age greater than or equal to 19 years of age
- History of atrial fibrillation with successful cardioversion to sinus rhythm
- Informed consent to participate in the study
Exclusion
- Failure of cardioversion to sinus rhythm
- Use of anti-arrythmic drug therapy
- Refusal to participate in the study
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00818012
Start Date
August 1 2008
End Date
June 1 2013
Last Update
August 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Creighton University Medical Center
Omaha, Nebraska, United States, 68131